Detalhe da pesquisa
1.
A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
Front Immunol
; 15: 1317522, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38524132
2.
A diversity of novel type-2 innate lymphoid cell subpopulations revealed during tumour expansion.
Commun Biol
; 7(1): 12, 2024 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172434
3.
Curcuphenol possesses an unusual histone deacetylase enhancing activity that counters immune escape in metastatic tumours.
Front Pharmacol
; 14: 1119620, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37637416
4.
A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours.
Front Pharmacol
; 14: 1119607, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37256225
5.
Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours.
Front Immunol
; 13: 982082, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36923728
6.
Serum free culture for the expansion and study of type 2 innate lymphoid cells.
Sci Rep
; 11(1): 12233, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34112824
7.
Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis.
Sci Rep
; 8(1): 2924, 2018 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29440650
8.
Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33.
Sci Rep
; 6: 30555, 2016 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27619158